These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34048716)

  • 1. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial.
    Ruffles TJC; Goyal V; Marchant JM; Masters IB; Yerkovich S; Buntain H; Cook A; Schultz A; Upham JW; Champion A; Versteegh L; Chang AB
    Lancet Respir Med; 2021 Oct; 9(10):1121-1129. PubMed ID: 34048716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough.
    Marchant J; Masters IB; Champion A; Petsky H; Chang AB
    Thorax; 2012 Aug; 67(8):689-93. PubMed ID: 22628120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics for prolonged wet cough in children.
    Marchant JM; Petsky HL; Morris PS; Chang AB
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD004822. PubMed ID: 30062732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT.
    Barratt S; Bielicki JA; Dunn D; Faust SN; Finn A; Harper L; Jackson P; Lyttle MD; Powell CV; Rogers L; Roland D; Stöhr W; Sturgeon K; Vitale E; Wan M; Gibb DM; Sharland M
    Health Technol Assess; 2021 Nov; 25(60):1-72. PubMed ID: 34738518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial.
    O'Grady KA; Grimwood K; Cripps A; Mulholland EK; Morris P; Torzillo PJ; Wood N; Smith-Vaughan H; Revell A; Wilson A; Van Asperen P; Richmond P; Thornton R; Rablin S; Chang AB
    Trials; 2013 Sep; 14():282. PubMed ID: 24010917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in health outcomes for First Nations children with chronic wet cough: rationale and study protocol for a multi-centre implementation science study.
    Laird PJ; Walker R; McCallum G; Toombs M; Barwick M; Morris P; Aitken R; Cooper M; Norman R; Patel B; Lau G; Chang AB; Schultz A
    BMC Pulm Med; 2022 Dec; 22(1):492. PubMed ID: 36581812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial.
    McCallum GB; Fong SM; Grimwood K; Nathan AM; Byrnes CA; Ooi MH; Nachiappan N; Saari N; Morris PS; Yeo TW; Ware RS; Elogius BW; Oguoma VM; Yerkovich ST; de Bruyne J; Lawrence KA; Lee B; Upham JW; Torzillo PJ; Chang AB
    Pediatr Infect Dis J; 2022 Jul; 41(7):549-555. PubMed ID: 35476706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial.
    Little P; Francis NA; Stuart B; O'Reilly G; Thompson N; Becque T; Hay AD; Wang K; Sharland M; Harnden A; Yao G; Raftery J; Zhu S; Little J; Hookham C; Rowley K; Euden J; Harman K; Coenen S; Read RC; Woods C; Butler CC; Faust SN; Leydon G; Wan M; Hood K; Whitehurst J; Richards-Hall S; Smith P; Thomas M; Moore M; Verheij T
    Lancet; 2021 Oct; 398(10309):1417-1426. PubMed ID: 34562391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial.
    Dinh A; Ropers J; Duran C; Davido B; Deconinck L; Matt M; Senard O; Lagrange A; Makhloufi S; Mellon G; de Lastours V; Bouchand F; Mathieu E; Kahn JE; Rouveix E; Grenet J; Dumoulin J; Chinet T; Pépin M; Delcey V; Diamantis S; Benhamou D; Vitrat V; Dombret MC; Renaud B; Perronne C; Claessens YE; Labarère J; Bedos JP; Aegerter P; Crémieux AC;
    Lancet; 2021 Mar; 397(10280):1195-1203. PubMed ID: 33773631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial.
    Valery PC; Morris PS; Byrnes CA; Grimwood K; Torzillo PJ; Bauert PA; Masters IB; Diaz A; McCallum GB; Mobberley C; Tjhung I; Hare KM; Ware RS; Chang AB
    Lancet Respir Med; 2013 Oct; 1(8):610-620. PubMed ID: 24461664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S; Breton J; Wynne B
    Antimicrob Agents Chemother; 2005 Jan; 49(1):153-60. PubMed ID: 15616290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
    Keij FM; Kornelisse RF; Hartwig NG; van der Sluijs-Bens J; van Beek RHT; van Driel A; van Rooij LGM; van Dalen-Vink I; Driessen GJA; Kenter S; von Lindern JS; Eijkemans M; Stam-Stigter GM; Qi H; van den Berg MM; Baartmans MGA; van der Meer-Kappelle LH; Meijssen CB; Norbruis OF; Heidema J; van Rossem MC; den Butter PCP; Allegaert K; Reiss IKM; Tramper-Stranders GA
    Lancet Child Adolesc Health; 2022 Nov; 6(11):799-809. PubMed ID: 36088952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled trial of antimicrobial treatment for acute otitis media.
    Tähtinen PA; Laine MK; Huovinen P; Jalava J; Ruuskanen O; Ruohola A
    N Engl J Med; 2011 Jan; 364(2):116-26. PubMed ID: 21226577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial.
    O'Grady KF; Grimwood K; Torzillo PJ; Rablin S; Lovie-Toon Y; Kaus M; Arnold D; Roberts J; Buntain H; Adsett D; King A; Scott M; Anderson J; Toombs M; Chang AB
    Lancet Child Adolesc Health; 2019 Dec; 3(12):889-898. PubMed ID: 31635952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four Month Outcomes of Extended- Versus Standard-course Antibiotic Therapy in Children Hospitalized With Pneumonia in High-risk Settings: A Randomized Controlled Trial.
    Kok HC; McCallum GB; Yerkovich ST; Grimwood K; Fong SM; Nathan AM; Byrnes CA; Ware RS; Nachiappan N; Saari N; Morris PS; Yeo TW; Oguoma VM; Masters IB; de Bruyne JA; Eg KP; Lee B; Ooi MH; Upham JW; Torzillo PJ; Chang AB
    Pediatr Infect Dis J; 2024 Sep; 43(9):872-879. PubMed ID: 38830139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.